Cargando…
Considerations on biologic agents in psoriasis with the new pregnancy lactation labeling rule()()
Autores principales: | Abrouk, Michael, Beroukhim, Keroush, Nakamura, Mio, Zhu, Tian Hao, Farahnik, Benjamin, Singh, Rasnik, Lee, Kristina, Koo, John, Bhutani, Tina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5419054/ https://www.ncbi.nlm.nih.gov/pubmed/28492043 http://dx.doi.org/10.1016/j.ijwd.2017.02.014 |
Ejemplares similares
-
Considerations on biologic agents in psoriasis with the new pregnancy lactation labeling rule()
por: Abrouk, Michael, et al.
Publicado: (2016) -
Ixekizumab for the Treatment of Psoriasis: A Review of Phase III Trials
por: Farahnik, Benjamin, et al.
Publicado: (2016) -
Brodalumab for the Treatment of Psoriasis: A Review of Phase III Trials
por: Farahnik, Benjamin, et al.
Publicado: (2016) -
Combining biologic and phototherapy treatments for psoriasis: safety, efficacy, and patient acceptability
por: Farahnik, Benjamin, et al.
Publicado: (2016) -
The Patient’s Guide to Psoriasis Treatment. Part 4: Goeckerman Therapy
por: Zhu, Tian Hao, et al.
Publicado: (2016)